Aarti Drugs reports consolidated Q1 FY23 PAT at Rs. 34.78 Cr
News

Aarti Drugs reports consolidated Q1 FY23 PAT at Rs. 34.78 Cr

Aarti Drugs Limited has reported total income of Rs. 622.22 crores during the quarter ended June 30, 2022.

  • By IPP Bureau | July 27, 2022

Aarti Drugs Limited has posted net profit of Rs. 34.78 crores for the quarter ended June 30, 2022 as against net profit of Rs.48.81 crores for the quarter ended June 30, 2021. The company posted net profit of Rs. 55.32 crores for the quarter ended March 31, 2022.

Aarti Drugs Limited has reported total income of Rs. 622.22 crores during the quarter ended June 30, 2022 as compared to Rs.581.57 crores during the quarter ended June 30, 2021. The company reported total income of Rs. 697.23 crores during the quarter ended March 31, 2022.

Upcoming E-conference

Other Related stories

Startup

Digitization